Ophthalmology

In the multivariate analyses, particulate matter of 2.5 μm or less (PM2.5) was linked with dry eye metrics when adjusted for demographic characteristics, comorbidities, medications, and interaction variables.

New research shows patients with both conditions have greater levels of particular cytokines and metabolic proteins.

A new analysis of more than 260 children is shedding light on associations between blood pressure and ophthalmic issues later in life.

After promising early findings for the investigative therapy in a rare form of blindness, investigators turn to the next phase.

New research from ARVO 2020 suggests patients with diabetic eye disease can still experiences losses in visual acuity, even with glycemic control.

A survey of 19 patients with hereditary retinitis pigmentosa details the impact of the disease on the quality of life and daily activity of patients and caregivers.

Gauging patient wellbeing prior to intravitreal injections may help inform clinicians as to who may fare worse with the treatment.

A breakdown of a new 12-month, phase 1b/2 assessment of the RNA therapy in patients with LCA10.

A new assessment shows about 60% of treatment-naive patients are not prescribed the most common drug class within 1 year of secondary edema.

The indication is just the second for a therapy treating the rare autoimmune disease.

Increased physical activity could reduce the risk of developing age-related cataracts by up to 10%.

Study investigators have completed what they call the most comprehensive characterization of elementary school-age concussions to date.

A Q&A with Anne Fung, MD, Global Development Lead for the Port Delivery System with ranibizumab at Genentech.

A new study from the University of Rochester indicates early intervention could help preserve or even restore visual abilities in stroke patients.

Young Kim, PhD, discusses the use of a smartphone app that helps clinicians assess patients for anemia.

An optometrist from Europe discusses the current state of glaucoma from identification to treatment.

Two colleagues from the Lewis Katz School of Medicine discuss the promise of AI to detect diabetic retinopathy.

New research suggests the presence of either condition can wreak havoc on an older adult's ability for movement, self-care, and household activities.

A new AI model from the New York Eye and Ear Infirmary of Mount Sinai boasts 99.2% accuracy for diagnosing intermediate or late AMD.

Discussing the results of a study examining impact of vitamin D and homotaurine supplementation on early to intermediate age-related macular degeneration.

Fortified vancomycin causes antibiotic resistance and corneal toxicity.

Rishi Singh, MD, discusses differences in disease activity noted among nAMD patients enrolled in the pivotal HAWK and HARRIER trials.

Discussing what data from fellow eyes of a 3-year study tell us about disease course of non-infectious uveitis of the posterior segment with an assistant professor from the Cole Eye Institute.

Male sex and younger age are also risk factors for premature stent extrusion.

A Q&A with the medical director of clinical ophthalmology with Genentech about the humanized monoclonal antibody in treatment of NMOSD.